kidneylifescience.ca valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
Meta Tags
Title Institute of Kidney Lifescience
Description SGLT2 Home Archived Resources About IKLT More than 1.9 million Canadians have Chronic Kidney Disease. We hope to reduce the burden of disease by early identific
Keywords N/A
Server Information
WebSite kidneylifescience faviconkidneylifescience.ca
Host IP 155.138.142.35
Location United States
Related Websites
Site Rank
More to Explore
kidneylifescience.ca Valuation
US$256,444
Last updated: 2022-06-13 11:17:06

kidneylifescience.ca has Semrush global rank of 41,273,431. kidneylifescience.ca has an estimated worth of US$ 256,444, based on its estimated Ads revenue. kidneylifescience.ca receives approximately 29,590 unique visitors each day. Its web server is located in United States, with IP address 155.138.142.35. According to SiteAdvisor, kidneylifescience.ca is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$256,444
Daily Ads Revenue US$237
Monthly Ads Revenue US$7,102
Yearly Ads Revenue US$85,219
Daily Unique Visitors 1,973
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
kidneylifescience.ca. A 600 IP: 155.138.142.35
kidneylifescience.ca. NS 3600 NS Record: ns14.domaincontrol.com.
kidneylifescience.ca. NS 3600 NS Record: ns13.domaincontrol.com.
HtmlToTextCheckTime:2022-06-13 11:17:06
Home Archived Resources About IKLT More than 1.9 million Canadians have Chronic Kidney Disease. We hope to reduce the burden of disease by early identification and prevention through education. RECORDINGS RESOURCES FAQ --> SGLT2 Inhibitors SGLT2 inhibition has been shown to provide cardioprotective and renal protective effects. In this talk, Dr. Robert Ting presents recent clinical data on SGLT2i and reviews their place in the management of Canadians patients with chronic kidney disease (CKD), with or without type 2 diabetes (T2D). SGLT2 inhibitors Presentation --> Proteinuria Primer Albuminuria is associated with a higher risk of progressive renal disease leading to dialysis, and more importantly, a greater risk of cardiovascular (CV) outcomes. This presentation by Dr. Sheldon Tobe examines the impact of proteinuria and its treatment on clinical outcomes. Novel approaches discussed included the use of sodium-glucose cotransporter-2 inhibitors (SGLT2i) and non-steroidal
HTTP Headers
HTTP/1.1 301 Moved Permanently
Server: nginx
Date: Wed, 20 Oct 2021 17:42:04 GMT
Content-Type: text/html
Content-Length: 162
Connection: keep-alive
Location: https://kidneylifescience.ca/

HTTP/2 200 
server: nginx
date: Wed, 20 Oct 2021 17:42:05 GMT
content-type: text/html; charset=utf-8
content-length: 40444
vary: Accept-Encoding
cache-provider: CLOUDWAYS-CACHE-DE
last-modified: Wed, 20 Oct 2021 12:37:32 GMT
vary: Accept-Encoding
age: 3816
x-cache: HIT
accept-ranges: bytes
kidneylifescience.ca Whois Information
Domain Name: kidneylifescience.ca
Registry Domain ID: D356364-CIRA
Registrar WHOIS Server: whois.ca.fury.ca
Registrar URL: ca.godaddy.com
Updated Date: 2021-03-24T05:05:28Z
Creation Date: 2006-02-07T20:25:50Z
Registry Expiry Date: 2022-02-07T05:00:00Z
Registrar: Go Daddy Domains Canada, Inc
Registrar IANA ID: not applicable
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: ns13.domaincontrol.com
Name Server: ns14.domaincontrol.com
DNSSEC: unsigned
>>> Last update of WHOIS database: 2021-09-09T07:32:01Z <<<